Dr. Rod D. Serry, MD

Dr. Serry practices at Poway Surgery Center in Poway, California.

Dr. Serry's NPI, 1912945130, was assigned on June 2, 2006. Dr. Serry graduated from Rush Medical College in 1996. Dr. Serry holds California license A76061.

Dr. Serry's primary practice is Poway Surgery Center, at 15611 Pomerado Rd, Poway, CA 92064. The practice phone is (858) 521-0031.

Dr. Serry's primary practice is Poway Surgery Center in Poway, California. Dr. Serry is also affiliated with Palomar UC San Diego Health Poway. The medical group on file is Palomar Health Medical Group. Dmand AI also links Dr. Serry to 1 more hospital, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Serry practices, 4 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Serry's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Serry is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Serry's licenses on file in 2 states: California and Illinois.

Dmand AI lists angioplasty, cardiac catheterization and leg revascularization among the conditions Dr. Serry treats.

CMS data shows 2,253 Medicare services from Dr. Serry across 18 procedure codes in 2024, for 532 Medicare patients. Medicare paid $113,177 for them.

CMS counts 532 Medicare patients who saw Dr. Serry in 2024. The largest group is 75 to 84, with 207 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 23% are also on Medicaid. Their average risk score is 1.94, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Serry's median patient age at 74, with 43% women.

In 2024, Dr. Serry wrote 616 Medicare Part D claims for 129 patients. 88% of them were for generic drugs. CMS names the drug for 502 of them, across 15 drugs with 11 or more claims each, at $71,337 in total drug cost. In 2023, CMS named 552 claims across 14 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 23 out of 100 for Dr. Serry for performance year 2024, reported individually. Dr. Serry accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 29 procedures of coronary angioplasty and stenting by Dr. Serry, more than 64% of the clinicians it reports for that procedure.

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 4 papers to Dr. Serry. Dr. Serry's most frequent co-authors are Kelly J. Bethel, MD, Thomas C. Bower, MD and Samir B. Damani, MD.

CMS Open Payments shows 346 general payments to Dr. Serry from 32 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 73% of the total. Edwards Lifesciences Corporation paid the most, $46,014.

Dmand AI lists 3 awards for Dr. Serry, most recently Top Doctors:San Diego Area in 2013.

Dr. Serry graduated from Rush Medical College in 1996. Dr. Serry is a member of ACC.

Dr. Serry is in network with 10 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.